Tribune Therapeutics
SwedenEntry
2021
Hold
5yr
Status
Active
Who owns Tribune Therapeutics?
Tribune Therapeutics is currently owned by Novo Holdings through Novo Holdings Venture Investments (1999 vintage), since 2021. Across its history, Tribune Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-07
Most recent investor
Novo HoldingsNovo Holdings Venture Investments · 1999 · VC
3 ownership periods · full history below
Key facts
HQSweden
SectorBiotech
StatusActive
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2021 · present
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Venture Investments · 1999 · VC
LifeArcActive
2025 · present(1yr) · LifeArc Ventures · 1992 · Life Sciences VC
IndustrifondenActive
2025 · present(1yr) · Industrifonden Evergreen · 1991 · VC
More from Novo Holdings Venture Investments
Other portfolio companies in the same fund.
US
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Tribune Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Tribune Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Tribune Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue